Novo Nordisk announced plans for a longer phase III trial testing its investigational obesity drug CagriSema, with regulatory ...

Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...

Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...

Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...

A decades-long study of Danish conscripts finds that despite the rise in obesity, the inverse relationship between intelligence and BMI has remained unchanged.

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

High consumption of ultraprocessed foods containing high levels of added sugars, saturated fat, and sodium is associated with obesity in early childhood, especially in boys.

Pediatric obesity was associated with a higher prevalence of iron deficiency but not a higher prevalence of iron deficiency anemia.

More than 40 percent of Qataris are clinically obese, due to sedentary lifestyles, genetic factors, and cultural preferences ...

Ultraprocessed food consumption in preschoolers is associated with increased body fat, particularly in boys, underscoring the ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...